Predixian Trademark Details

This mark is dead with a status of Abandoned-Failure to Respond or Late Response. The last case file activity for this mark occured 22 years ago on Tuesday, August 7, 2001, according to the United State Patent & Trademark Office
Word Mark Predixian
Status Dead 602 — Abandoned-Failure to Respond or Late Response

Current Owner

Texas Biotechnology Corporation of Houston, TX

View all trademarks for Texas Biotechnology Corporation
Other Trademarks for Texas Biotechnology Corporation
Serial Number 76081563
Status Date Tuesday, August 7, 2001
Filing Date Tuesday, August 7, 2001
Attorney Martin L. Katz

Correspondent

MARTIN L. KATZ
ROCKEY, MILNAMOW & KATZ, LTD.
TWO PRUDENTIAL PLAZA, SUITE 4700
180 NORTH STETSON
CHICAGO, ILLINOIS 60601

Case File Statements

Goods & Services Pharmaceutical products for use as an anticoagulant and for the treatment of heparin-induced thrombocytopenia with or without thrombosis, acute coronary syndromes, ischemic stroke, percutaneous coronary interventions, venous thrombosis, arterial thrombosis, coagulopathies, pulmonary embolism, peripheral embolism and hemodialysis

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Monday, August 7, 2000
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.